Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 4, 2025
Does transurethral resection of prostate increase toxicity risk after simultaneous integrated boost radiotherapy? A matched cohort study with long-term follow-upAysenur Elmali, Birhan Demirhan, Ozan Cem Guler, et al.
Acta Oncologica (Stockholm, Sweden)|November 6, 2024
The impact of age on clinicopathological features and treatment results in patients with localised prostate cancer receiving definitive radiotherapyCem Onal, Ozan Cem Guler, Aysenur Elmali, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 5, 2024
Long-term analysis of hematological parameters as predictors of recurrence patterns and treatment outcomes in cervical cancer patients undergoing definitive chemoradiotherapyAysenur Elmali, Ozan Cem Guler, Birhan Demirhan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 11, 2025
Predictive utility of Post-Treatment tumor apparent diffusion coefficient in High-Risk prostate cancer undergoing definitive Radiotherapy: A Long-Term outcome analysisCem Onal, Gurcan Erbay, Ozan Cem Guler, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 28, 2025
Optimizing treatment for Gleason 10 prostate cancer: radiation dose escalation and 68Ga-PSMA-PET/CT stagingCem Onal, Ozan Cem Guler, Birhan Demirhan, et al.
The Prostate|March 11, 2025
Propensity Score Matched Analysis of External Beam Radiotherapy With or Without Focal Boost to Intraprostatic Lesions in Prostate CancerCem Onal, Ozan Cem Guler, Gurcan Erbay, et al.
The Prostate|March 30, 2026
Impact of Intraprostatic Simultaneous Integrated Boost on Long-Term Outcomes in Unfavorable Intermediate-Risk Prostate Cancer Treated With Dose-Escalated Radiotherapy and Short-Term Androgen Deprivation TherapyCem Onal, Aysenur Elmali, Birhan Demirhan, et al.
Archivos Espanoles De Urologia|May 9, 2026
Development of a Novel Nomogram to Predict Biochemical Failure and Prostate Cancer-Specific Mortality After Definitive Radiotherapy in Patients with Gleason Score 7 Prostate CancerAysenur Elmal, Birhan Demirhan, Ertugrul Senturk, et al.
Urologic Oncology|July 16, 2026
Post-treatment diffusion MRI-derived apparent diffusion coefficient as a biomarker of response and prognosis following definitive radiotherapy for prostate cancer: Impact of focal dose escalation on ADC dynamicsCem Onal, Gurcan Erbay, Ozan Cem Guler, et al.
The Canadian Journal of Urology|September 5, 2025
National survey of radiotherapy and androgen deprivation therapy strategies with PSMA-PET/CT integration in intermediate-risk prostate cancer: TROD 09-007 studyAysenur Elmali, Birhan Demirhan, Caglayan Selenge Beduk Esen, et al.
Pageof 2